Skip to main content

SYSTEMATIC REVIEW article

Front. Neurol.

Sec. Experimental Therapeutics

Volume 16 - 2025 | doi: 10.3389/fneur.2025.1509291

Study on the Safety and Efficacy of Fu's Subcutaneous Needling (FSN) for the Treatment of Lumbar Disc Herniation: A Systematic Review and Meta Analysis of Randomised Controlled Trials

Provisionally accepted
Jiao Liang Jiao Liang 1Jin Zhang Jin Zhang 2Jie Zhou Jie Zhou 1Kun Yang Kun Yang 1Qian Xiong Qian Xiong 1*
  • 1 Chongqing Three Gorges Medical College, Chongqing, China
  • 2 Sichuan Provincial Construction Hospital, Chengdu, China

The final, formatted version of the article will be published soon.

    Systematic evaluation of the effectiveness and safety of Fu's Subcutaneous Needling in the treatment of Lumbar Disc Herniation.Methods: A systematic search was conducted across four Chinese and four English databases, including China National Knowledge Infrastructure (CNKI), Wanfang, China Science and Technology Journal Database(VIP), China Biology Medicine (CBM), PubMed, Cochrane Library, Embase, and Web of Science, to collect randomized controlled trials (RCTs) on the use of Fu's subcutaneous needling for the treatment of lumbar disc herniation published before September 1, 2024. The search was conducted in both Chinese and English, with no restrictions on ethnicity. After rigorous screening of the literature, Meta-analysis was performed using Stata 18.0 and RevMan 5.2.1 software. This study protocol has been registered with the PROSPERO International Prospective Register of Systematic Reviews, with a registration number CRD42024595890.Results: A total of 17 studies involving 1,467 patients were included. The Meta-analysis results indicated that Fu's subcutaneous needling for lumbar disc herniation was more effective than the control group, with a statistically significant difference. The overall effective rate was: OR=2.77, 95% CI [1.90,4.03], Z=5.31, P<0.00001. The VAS score was: MD=

    Keywords: Fu's Subcutaneous Needling, Lumbar disc herniation, Pain Management, clinical research, efficacy evaluation

    Received: 17 Oct 2024; Accepted: 31 Mar 2025.

    Copyright: © 2025 Liang, Zhang, Zhou, Yang and Xiong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Qian Xiong, Chongqing Three Gorges Medical College, Chongqing, 404120, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    95% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more